Skip to main content
OpenTrials

Clinical trial condition

Pediatric Solid Tumor

Explore clinical trials studying Pediatric Solid Tumor. Study availability and eligibility vary by location and protocol.

19 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Pediatric Solid Tumor trial results

Completed

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

NCT02564198

Conditions
CNS Malignancies, Central Nervous System Neoplasms, Disease Attributes, +10 more
Locations
  • Childrens Hospital of Alabama Birmingham, Alabama, United States
  • Children's Oncology Group Monrovia, California, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 21 locations
View Trial Details
Completed

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

NCT03222258

Conditions
Biliary Cancer Metastatic, Breast Diseases, Breast Neoplasms, +40 more
Locations
  • National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Gyeongsang National University Hospital Jinju, Gyeongsangnam-do, South Korea
  • Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea
View all 15 locations
View Trial Details
Completed

iCAT for Recurrent/Refractory/HR Solid Tumors

NCT01853345

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Female Urogenital Diseases, +29 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

NCT02520713

Conditions
Pediatric Solid Tumor
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Comer Children's Hospital Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions